Sponsor:
Serina Therapeutics
Code:
NCT07422675
Conditions
PARKINSON DISEASE (Disorder)
Advanced Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
SER-252 (PEOZ-apomorphine)
enFuse
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-03. This information was provided to ClinicalTrials.gov by Serina Therapeutics on 2026-04-21.